Corpus Intelligence IC Memo — BROOKVILLE HOSPITAL 2026-04-26 19:00 UTC
IC Memo — BROOKVILLE HOSPITAL
Investment Committee Memorandum | PA | 25 beds | Grade C | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BROOKVILLE HOSPITAL

CCN 391312 | JEFFERSON, PA | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BROOKVILLE HOSPITAL is a 25-bed suburban community hospital in JEFFERSON, PA with $30.4M in net patient revenue and a -3.0% operating margin. The hospital serves a payer mix of 36.7% Medicare, 0.2% Medicaid, and 63.1% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.0% to 4.3% (+736bps).

Net Revenue HCRIS$30.4M
Current EBITDA COMPUTED$-926K
Operating Margin COMPUTED-3.0%
Occupancy HCRIS33.7%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS36.4%
Distress Probability ML51.8%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
58
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -3.0% places it above the state median. Among 58 size-comparable peers (12-50 beds), the median margin is -1.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BROOKVILLE HOSPITAL (Target)PA25$30.4M-3.0%
OSS ORTHOPAEDIC HOSPITALPA30$149.4M-5.0%
WELLSPAN SURGERY AND REHAB HOSPA25$120.2M2.8%
UPMC LITITZPA36$114.5M14.2%
MINERS MEMORIAL MEDICAL CENTERPA49$107.7M12.4%
LVH-COORDINATED ALLENTOWNPA20$89.6M2.3%
CHARLES COLE MEMORIAL HOSPITALPA25$88.1M-9.0%
POCONO MEDICAL CENTER DICKSON PA40$85.9M0.1%
WELLSBOROPA25$85.6M2.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$639K+210bp18mo
Cost to Collect4.5%2.5%$608K+200bp12mo
Denial Rate Reduction12.0%6.5%$602K+198bp12mo
A/R Days Reduction5200.0%3800.0%$370K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$639K
Cost to Collect
$608K
Denial Rate Reduction
$602K
A/R Days Reduction
$370K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$-926K
+ RCM Uplift+$2.2M
Pro Forma EBITDA$1.3M
Current Margin-3.0%
Pro Forma Margin4.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.4M$16.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.4M$17.4M0.00x-100.0%
Bull Case9.0x11.0x$-1.3M$24.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.3M$26.2M0.00x-100.0%
Bear Case11.0x10.0x$-1.6M$5.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.6M$5.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 51.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 12-50 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-20.1% / P50=-1.0% / P75=6.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.